We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.1B
AUM Growth
+$632M
Cap. Flow
+$447M
Cap. Flow %
14.4%
Top 10 Hldgs %
19.97%
Holding
560
New
236
Increased
69
Reduced
84
Closed
160

Top Buys

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$59.6M
2
SHW icon
Sherwin-Williams
SHW
+$57.5M
3
BBY icon
Best Buy
BBY
+$44.8M
4
SBAC icon
SBA Communications
SBAC
+$43.9M
5
NKE icon
Nike
NKE
+$36.3M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$67.6M
2
MSFT icon
Microsoft
MSFT
+$45.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$37.1M
4
MDU icon
MDU Resources
MDU
+$36.5M
5
BA icon
Boeing
BA
+$29.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.29%
2 Technology 12.47%
3 Industrials 10.27%
4 Healthcare 7.4%
5 Communication Services 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MREO
276
Mereo BioPharma
MREO
$51.1M
$919K 0.03%
278,588
+116,588
+72% +$395K
CELH icon
277
Celsius Holdings
CELH
$7.59B
$913K 0.03%
+11,016
New +$755K
MRUS
278
DELISTED
Merus
MRUS
$912K 0.03%
+20,250
New +$821K
IGV icon
279
iShares Expanded Tech-Software Sector ETF
IGV
$14.4B
$884K 0.03%
+10,365
New +$875K
GPCR icon
280
PUT
Structure Therapeutics
GPCR
$3.55B
$870K 0.03%
+20,300
New +$856K
GERN icon
281
Geron
GERN
$866M
$863K 0.03%
+261,397
New +$586K
MLTX icon
282
MoonLake Immunotherapeutics
MLTX
$1.52B
$859K 0.03%
+17,107
New +$928K
CORT icon
283
PUT
Corcept Therapeutics
CORT
$12B
$851K 0.03%
+33,800
New +$799K
MNTK icon
284
CALL
Montauk Renewables
MNTK
$243M
$851K 0.03%
+204,500
New +$1.28M
CLDX icon
285
PUT
Celldex Therapeutics
CLDX
$3.07B
$848K 0.03%
+20,200
New +$829K
BE icon
286
CALL
Bloom Energy
BE
$67.6B
$843K 0.03%
+75,000
New +$824K
TK icon
287
Teekay
TK
$975M
$827K 0.03%
+113,531
New +$890K
SOFI icon
288
PUT
SoFi Technologies
SOFI
$24B
$821K 0.03%
+112,500
New +$894K
MGTX icon
289
MeiraGTx Holdings
MGTX
$1.14B
$819K 0.03%
+135,000
New +$853K
MLCO icon
290
CALL
Melco Resorts & Entertainment
MLCO
$2.17B
$789K 0.03%
109,400
-1,114,700
-91% -$8.95M
VRDN icon
291
Viridian Therapeutics
VRDN
$2.27B
$775K 0.03%
+44,264
New +$858K
NATH icon
292
Nathan's Famous
NATH
$402M
$775K 0.03%
10,946
+1,586
+17% +$111K
PRAX icon
293
Praxis Precision Medicines
PRAX
$8.58B
$753K 0.02%
12,336
-5,664
-31% -$254K
XLRE icon
294
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.64B
$741K 0.02%
+18,750
New +$729K
BHVN icon
295
PUT
Biohaven
BHVN
$2.06B
$738K 0.02%
+13,500
New +$668K
BHC icon
296
PUT
Bausch Health
BHC
$2.39B
$716K 0.02%
+67,500
New +$590K
GNE icon
297
Genie Energy
GNE
$372M
$712K 0.02%
+47,224
New +$907K
AXSM icon
298
Axsome Therapeutics
AXSM
$10.9B
$710K 0.02%
8,896
+3,341
+60% +$280K
FRO icon
299
Frontline
FRO
$8.69B
$701K 0.02%
+30,000
New +$677K
CELC icon
300
Celcuity
CELC
$4.52B
$695K 0.02%
32,171
-79,074
-71% -$1.26M

Similar funds

J. Goldman & Co's Q1 2024 Portfolio in Review

As of Q1 2024, J. Goldman & Co held 560 positions worth $3.1B, up 26% from $2.47B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

J. Goldman & Co deployed $447M of net new capital in Q1 2024, opening 236 new positions and adding to 69 existing holdings. Its largest new stake was Sherwin-Williams: 180,485 shares worth $62.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was PayPal, an estimated $67.6M trimmed.

  • J. Goldman & Co's largest Q1 2024 buy was Sherwin-Williams: 180,485 shares worth $62.7M.
  • J. Goldman & Co added most to eBay in Q1 2024, an estimated $59.6M increase.
  • J. Goldman & Co's biggest Q1 2024 reduction was PayPal, cutting an estimated $67.6M.
  • J. Goldman & Co fully exited MDU Resources in Q1 2024, selling an estimated $36.5M.
  • J. Goldman & Co's ten largest holdings make up 20% of its $3.1B portfolio in Q1 2024.
  • J. Goldman & Co opened 236 new positions and closed 160 in Q1 2024.
  • J. Goldman & Co's portfolio value rose 26% quarter-over-quarter to $3.1B.

Based on J. Goldman & Co's 13F filing for Q1 2024, filed 15 May 2024.